TipRanks
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market
4594
BrightPath Biotherapeutics Co.Ltd.
RESEARCH TOOLSreports
Want to see JP:4594 full AI Analyst Report?

BrightPath Biotherapeutics Co.Ltd. (4594) Income Statement

0 Followers

BrightPath Biotherapeutics Co.Ltd. Income Statement

Last quarter (Q4 2025), BrightPath Biotherapeutics Co.Ltd.'s total revenue was ¥51.00K, a decrease of -95.11% from the same quarter last year. In Q4, BrightPath Biotherapeutics Co.Ltd.'s net income was ¥-349.86M. See BrightPath Biotherapeutics Co.Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 84.00K¥ 1.13M¥ 72.00K¥ 5.28M¥ 15.41M
Gross Profit
¥ 55.00K¥ 1.10M¥ -341.00K¥ -13.33M¥ -23.03M
Operating Expenses
¥ 1.30B¥ 1.16B¥ 1.15B¥ 1.45B¥ 1.45B
Depreciation and Amortization
¥ 0.00¥ 0.00¥ 395.00K¥ 16.72M¥ 35.12M
EBITDA
¥ -1.30B¥ -1.15B¥ -1.17B¥ -1.47B¥ -1.45B
Operating Income
¥ -1.29B¥ -1.16B¥ -1.16B¥ -1.47B¥ -1.48B
Other Income/Expenses
¥ -7.53M¥ 11.67M¥ -11.10M¥ -16.68M¥ -5.74M
Pretax Income
¥ -1.30B¥ -1.15B¥ -1.17B¥ -1.48B¥ -1.48B
Net Income
¥ -1.30B¥ -1.15B¥ -1.17B¥ -1.49B¥ -1.48B
Per Share Metrics
Basic EPS
¥ -11.70¥ -14.12¥ -18.21¥ -24.90¥ -28.55
Diluted EPS
¥ -11.70¥ -14.12¥ -18.21¥ -24.90¥ -28.55
Weighted Average Shares Outstanding
 111.56M 81.51M 64.16M 59.66M 51.99M
Weighted Average Shares Outstanding (Diluted)
 111.56M 81.51M 64.16M 59.66M 51.99M
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History